Home / Risperidone / Belgium
BE ATC N05AX08 · updated 2 Nov 2026
Risperidone shortage in Belgium
Is there a Risperidone shortage in Belgium?
Yes. As of 2 Nov 2026, 6 Risperidone products are reported short in Belgium, the first since 19 Feb 2024. The company estimate for the return is 6 Nov 2026 (latest 10 May 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, France, Italy, Spain, Ireland, Austria, Czechia, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Risperidone EG 6 mg film-coat. tabl. 100 (5 x 20) | EG | 19 Feb 2024 | 6 Nov 2026 | Manufacturing problem Delay in production |
| BE | Risperidone Teva 25 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial + pre-filled syr. 25 mg + 2 ml | Teva | 3 Oct 2025 | 5 May 2027 | Manufacturing problem Delay in production |
| BE | Risperidone Teva 37.5 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial + pre-filled syr. 37.5 mg + 2 ml | Teva | 5 Dec 2025 | 5 May 2027 | Manufacturing problem Delay in production |
| BE | Risperidone Teva 50 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial + pre-filled syr. 50 mg + 2 ml | Teva | 30 Mar 2026 | 10 May 2027 | Manufacturing problem Delay in production |
| BE | Risperidone EG 2 mg film-coat. tabl. 20 | EG | 30 Apr 2026 | 9 Nov 2026 | Other Other reason |
| BE | Risperdal 1 mg/ml or. sol. 100 ml | Janssen-Cilag | 27 Oct 2026 | 17 Nov 2026 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.